Mohammadi, M.; Roets, E.; Bleckman, R.F.; Oosten, A.W.; Grunhagen, D.; Desar, I.M.E.; Bonenkamp, H.; Reyners, A.K.L.; van Etten, B.; Hartgrink, H.;
et al. Impact of Mutation Profile on Outcomes of Neoadjuvant Therapy in GIST. Cancers 2025, 17, 634.
https://doi.org/10.3390/cancers17040634
AMA Style
Mohammadi M, Roets E, Bleckman RF, Oosten AW, Grunhagen D, Desar IME, Bonenkamp H, Reyners AKL, van Etten B, Hartgrink H,
et al. Impact of Mutation Profile on Outcomes of Neoadjuvant Therapy in GIST. Cancers. 2025; 17(4):634.
https://doi.org/10.3390/cancers17040634
Chicago/Turabian Style
Mohammadi, Mahmoud, Evelyne Roets, Roos F. Bleckman, Astrid W. Oosten, Dirk Grunhagen, Ingrid M. E. Desar, Han Bonenkamp, Anna K. L. Reyners, Boudewijn van Etten, Henk Hartgrink,
and et al. 2025. "Impact of Mutation Profile on Outcomes of Neoadjuvant Therapy in GIST" Cancers 17, no. 4: 634.
https://doi.org/10.3390/cancers17040634
APA Style
Mohammadi, M., Roets, E., Bleckman, R. F., Oosten, A. W., Grunhagen, D., Desar, I. M. E., Bonenkamp, H., Reyners, A. K. L., van Etten, B., Hartgrink, H., Fiocco, M., Schrage, Y., Steeghs, N., & Gelderblom, H.
(2025). Impact of Mutation Profile on Outcomes of Neoadjuvant Therapy in GIST. Cancers, 17(4), 634.
https://doi.org/10.3390/cancers17040634
